Financial Perspectives’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Hold |
350
| – | – | 0.01% | 403 |
|
|
2025
Q1 | $22.2K | Hold |
350
| – | – | 0.01% | 400 |
|
|
2024
Q4 | $23.3K | Hold |
350
| – | – | 0.01% | 392 |
|
|
2024
Q3 | $24.4K | Hold |
350
| – | – | 0.01% | 366 |
|
|
2024
Q2 | $22.7K | Hold |
350
| – | – | 0.01% | 366 |
|
|
2024
Q1 | $22.7K | Hold |
350
| – | – | 0.01% | 365 |
|
|
2023
Q4 | $23K | Hold |
350
| – | – | 0.01% | 365 |
|
|
2023
Q3 | $20K | Hold |
350
| – | – | 0.01% | 361 |
|
|
2023
Q2 | $21.5K | Hold |
350
| – | – | 0.01% | 358 |
|
|
2023
Q1 | $22K | Hold |
350
| – | – | 0.01% | 348 |
|
|
2022
Q4 | $22.2K | Hold |
350
| – | – | 0.01% | 342 |
|
|
2022
Q3 | $20.6K | Hold |
350
| – | – | 0.01% | 343 |
|
|
2022
Q2 | $20.2K | Hold |
350
| – | – | 0.01% | 347 |
|
|
2022
Q1 | $21.7K | Hold |
350
| – | – | 0.01% | 357 |
|
|
2021
Q4 | $24.9K | Hold |
350
| – | – | 0.01% | 327 |
|
|
2021
Q3 | $26.2K | Hold |
350
| – | – | 0.01% | 326 |
|
|
2021
Q2 | $27.1K | Sell |
350
-25,487
| -99% | -$1.97M | 0.01% | 342 |
|
|
2021
Q1 | $350K | Buy |
25,837
+25,487
| +7,282% | +$345K | 0.02% | 333 |
|
|
2020
Q4 | $24.5K | Hold |
350
| – | – | 0.01% | 311 |
|
|
2020
Q3 | $19.8K | Hold |
350
| – | – | 0.01% | 292 |
|
|
2020
Q2 | $20.4K | Hold |
350
| – | – | 0.01% | 272 |
|
|
2020
Q1 | $16.3K | Hold |
350
| – | – | 0.01% | 266 |
|
|
2019
Q4 | $19.5K | Buy |
+350
| New | +$19.5K | 0.01% | 260 |
|